NivolumabCytokine-release-syndrome and derangement of renal function secondary to tumour-lysis-syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1687卷 / 1期

关键词：

D O I：

10.1007/s40278-018-41593-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：172 / 172

相关论文

共 50 条

[21] SorafenibFatal tumour lysis syndrome: case report
Reactions Weekly, 2010, 1292 (1) : 34 - 34
[22] VenetoclaxClinical tumour lysis syndrome: case report
Reactions Weekly, 2023, 1947 (1) : 408 - 408
[23] RituximabHyperacute tumour lysis syndrome: case report
Reactions Weekly, 2015, 1549 (1) : 217 - 217
[24] AntineoplasticsFatal tumour lysis syndrome: case report
Reactions Weekly, 2000, 809 (1) : 7 - 7
[25] RituximabAcute tumour lysis syndrome: case report
Reactions Weekly, 2006, 1088 (1) : 20 - 20
[26] AntineoplasticsFatal tumour lysis syndrome: case report
Reactions Weekly, 2000, 827 (1) : 6 - 6
[27] IohexolSpontaneous tumour lysis syndrome: case report
Reactions Weekly, 2014, 1514 (1) : 26 - 26
[28] AntineoplasticsFatal tumour lysis syndrome: case report
Reactions Weekly, 2010, 1295-1296 (1) : 7 - 7
[29] AdenosineSpontaneous tumour lysis syndrome: case report
Reactions Weekly, 2020, 1810 (1) : 17 - 17
[30] NilotinibFirst report of tumour lysis syndrome: case report
Reactions Weekly, 2008, 1193 (1) : 21 - 21

← 1 2 3 4 5 →